Literature DB >> 30312023

Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Cheng Zhang1, Ping Wang2, Yongqiang Li1, Changxin Huang1, Wei Ni1, Yidan Chen1, Junping Shi1, Gongying Chen1, Xiangrong Hu1, Meng Ye2, Shiwei Duan2, Kaifeng Wang1.   

Abstract

Hepatocellular carcinoma (HCC) is a prevalent liver malignancy that can be developed from nonalcoholic fatty liver disease (NAFLD). Numerous pathophysiological alterations, including insulin resistance, specific cytokine release, oxidative stress, and mitochondrial damage, are involved in the transition of NAFLD to cirrhosis and HCC. MicroRNAs, as post-transcriptional modulators, play a critical role in the pathogenesis of NAFLD-related HCC by regulating lipid metabolism, glucose homeostasis, cell proliferation, apoptosis, migration, and differentiation. This review summarizes the current progress of microRNAs in the risk and prognosis of NAFLD-related HCC. Anat Rec, 302:193-200, 2019.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatocellular carcinoma; microRNA; nonalcoholic fatty liver disease; therapy

Mesh:

Substances:

Year:  2018        PMID: 30312023     DOI: 10.1002/ar.23954

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  3 in total

Review 1.  A Brief Overview of Oxidative Stress in Adipose Tissue with a Therapeutic Approach to Taking Antioxidant Supplements.

Authors:  Shima Taherkhani; Katsuhiko Suzuki; Ruheea Taskin Ruhee
Journal:  Antioxidants (Basel)       Date:  2021-04-13

2.  Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades.

Authors:  Yang Ge; Pengfei Gu; Wenbo Wang; Liyuan Cao; Lulu Zhang; Jingquan Li; Wei Mu; Hui Wang
Journal:  J Mol Cell Biol       Date:  2021-08-27       Impact factor: 6.216

3.  Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma.

Authors:  Chaosen Yue; Yaoyao Ren; Hua Ge; Chaojie Liang; Yingchen Xu; Guangming Li; Jixiang Wu
Journal:  Onco Targets Ther       Date:  2019-01-14       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.